Wellgistics Health Files 8-K on Operations & Financials

TL;DR

Wellgistics Health dropped an 8-K detailing its financials and operations - check it out.

AI Summary

Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on August 22, 2025, reporting events as of August 20, 2025. The filing pertains to results of operations, financial condition, and includes Regulation FD disclosures and financial statements. The company is incorporated in Delaware and headquartered in Tampa, Florida.

Why It Matters

This 8-K filing provides updates on Wellgistics Health's operational and financial status, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a standard 8-K reporting operational and financial information, not indicating any immediate or unusual risks.

Key Players & Entities

• Wellgistics Health, Inc. (company) — Registrant
• Danam Health, Inc. (company) — Former company name
• August 20, 2025 (date) — Earliest event reported
• August 22, 2025 (date) — Filing date
• 3000 Bayport Drive Suite 950 Tampa, FL 33607 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share WGRX The Nasdaq Stock Mar

Filing Documents

• form8-k.htm (8-K) — 39KB
• ex99-1.htm (EX-99.1) — 30KB
• 0001641172-25-025238.txt ( ) — 239KB
• wgrx-20250820.xsd (EX-101.SCH) — 3KB
• wgrx-20250820_lab.xml (EX-101.LAB) — 33KB
• wgrx-20250820_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 4KB

02 Results of Operations

Item 2.02 Results of Operations and Financial Condition. To the extent required, the information set forth under Item 7.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.02. The information furnished under this Item 2.02, including the referenced exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by reference to such filing. Item 7.01. Regulation FD Disclosure. On August 20, 2025, the Company issued a press release announcing the Company's financial results for the second fiscal quarter ended June 30, 2025. The press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference. The press release shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of such Section 18. The information in this Item 7.01, as well as Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act regardless of any general incorporation language in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release by Wellgistics Health, Inc., dated August 20, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Wellgistics Health, Inc. Dated: August 22, 2025 By: /s/ Mark DiSiena Mark DiSiena Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR